Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity
about
sameAs
Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC)EphA receptor signaling--complexity and emerging themesEphs and Ephrins in malignant gliomasBasic fibroblast growth factor stimulates activation of Rac1 through a p85 betaPIX phosphorylation-dependent pathwayRho GTPases regulate PTPmu-mediated nasal neurite outgrowth and temporal repulsion of retinal ganglion cell neuronsThe EphA8 receptor induces sustained MAP kinase activation to promote neurite outgrowth in neuronal cellsTargeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in miceA subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity.Ephrin-A5 suppresses neurotrophin evoked neuronal motility, ERK activation and gene expression.EphA3 functions are regulated by collaborating phosphotyrosine residuesBacterial urease and its role in long-lasting human diseases.EphA activation overrides the presynaptic actions of BDNF.EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell linesEph receptors and ephrins as targets for cancer therapy.Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsInvestigation of the interactions between the EphB2 receptor and SNEW peptide variants.Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway.Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer.Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.Deciphering proteins and their functions in the regenerating retina.Eph-dependent cell-cell adhesion and segregation in development and cancer.Therapeutic targeting of EPH receptors and their ligands.Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomasCrosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.Ephrin-B reverse signaling induces expression of wound healing associated genes in IEC-6 intestinal epithelial cellsEphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation.Ephrin-A3 reverse signaling regulates hippocampal neuronal damage and astrocytic glutamate transport after transient global ischemia.Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery.Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous system
P2860
Q24300682-98560252-7CE1-46D1-BE4B-C093D8B42564Q24648024-3319851D-6C63-4051-9EDB-EDB8DBDBDD61Q26864082-929151EC-9E7D-4E16-AF5D-09B9E5E084B9Q27015780-65D819BF-9D1F-4DD9-88F8-CC32E1EEA42AQ28209505-36F31D10-C82B-4AEF-B41E-BC534F9512EEQ28283977-7D3E0701-496F-48DC-AB1F-7D726E61AE3FQ28585285-1C2ED497-47A1-42E9-BC0C-7B5AA96055B4Q28593557-342F8AFE-A523-4AD0-9460-B1A73BD4AF32Q30490503-D3821079-1513-4CC3-88C1-25ED26D2C795Q33872553-33940922-0443-4740-871E-FC522063A675Q34055981-2BB51B54-56D5-4D73-BBD7-59A48E4FC3FBQ34267791-8BAD8858-5136-4CA5-9694-F343B84CDC87Q34543712-579090A9-545A-4C49-9844-12786D73B747Q34980169-145A0F89-DAF6-4CE6-868A-A4F5353BFCDCQ35211013-647AA855-D906-477D-B41B-CFF4A006EA4DQ35370195-F362205A-9D5B-47DC-AB43-5E98A767E765Q35621005-3F5F9B98-9062-4928-A040-690FA6E3848FQ36232264-BCDF3234-1339-48A5-AD21-FFDEC623716BQ36993347-09319DC8-464B-4663-BA0E-00F52892909DQ37171153-322CD472-2D4F-4220-9E71-24963FA73CE6Q37185221-5253D6D0-F26B-4DD0-97DB-69C83FBC4086Q37802881-16F28E73-7AB0-4636-8C90-E1976E18B040Q37971902-8168141C-49BD-424B-A1F9-165640C9B525Q38174793-6E1CD538-C5DD-4A21-8CF3-F2287D307C1EQ39606000-C12FD0A6-E0C7-4783-A2CB-B746C2694C27Q39656465-B722C4CB-214F-482F-A80C-694C1054978EQ39676351-DF8247BF-027B-4950-9261-3A0FAB8F8E9DQ40392006-0F609CAE-F506-41C8-A993-C395FB5D485BQ40653046-A2856179-8C7A-467A-BE2A-07F25613083BQ48650566-80D3B9B0-CF9A-4BB8-BF7A-DC940E130774Q49884500-DFE6738D-4372-40F9-A45C-49C55ADADF8DQ58805400-823FD3C2-071D-42B7-8D50-0C01A834F5D5
P2860
Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Manipulation of EphB2 regulato ...... naling and biological activity
@ast
Manipulation of EphB2 regulato ...... naling and biological activity
@en
Manipulation of EphB2 regulato ...... naling and biological activity
@nl
type
label
Manipulation of EphB2 regulato ...... naling and biological activity
@ast
Manipulation of EphB2 regulato ...... naling and biological activity
@en
Manipulation of EphB2 regulato ...... naling and biological activity
@nl
prefLabel
Manipulation of EphB2 regulato ...... naling and biological activity
@ast
Manipulation of EphB2 regulato ...... naling and biological activity
@en
Manipulation of EphB2 regulato ...... naling and biological activity
@nl
P2093
P2860
P356
P1476
Manipulation of EphB2 regulato ...... naling and biological activity
@en
P2093
Jiefei Tong
Piers Nash
Sabine Elowe
P2860
P304
P356
10.1074/JBC.M208972200
P407
P577
2003-02-21T00:00:00Z